Viewing Study NCT03045393


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-01-29 @ 3:52 AM
Study NCT ID: NCT03045393
Status: WITHDRAWN
Last Update Posted: 2018-07-05
First Post: 2017-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC
Sponsor: Duke University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module